Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Gerald WL, Rosai J. Desmoplastic small cell tumor with divergent differentiation. Pediatr. Pathol. 9(2), 177–183 (1989).
  Medline CASGoogle Scholar
• 2 Umeda K, Saida S, Yamaguchi H et al. Central nervous system recurrence of desmoplastic small round cell tumor following aggressive multimodal therapy: a case report. Oncol. Lett. 11(1), 856–860 (2016).
  MedlineGoogle Scholar
• 3 Lal DR, Su WT, Wolden SL, Loh KC, Modak S, La Quaglia MP. Results of multimodal treatment for desmoplastic small round cell tumors. J. Pediatr. Surg. 40(1), 251–255 (2005).
  MedlineGoogle Scholar
• 4 Ladanyi M, Gerald WL. Specificity of the EWS/WT1 gene fusion for desmoplastic small round cell tumour. J. Pathol. 180(4), 462 (1996). • Emphasizes the importance and specificity of the EWS/WT1 fusion gene for diagnosis of desmoplastic small round cell tumors.
  Medline CASGoogle Scholar
• 5 Lee SB, Kolquist KA, Nichols K et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat. Genet. 17(3), 309–313 (1997).
  Medline CASGoogle Scholar
• 6 Karnieli E, Werner H, Rauscher FJ 3rd, Benjamin LE, LeRoith D. The IGF-receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms’ tumor 1 fusion protein. J. Biol. Chem. 271(32), 19304–19309 (1996).
  Medline CASGoogle Scholar
• 7 Saito T, Yokotsuka M, Motoi T et al. EWS-WT1 chimeric protein in desmoplastic small round cell tumor is a potent transactivator of FGFR4. Cancer Sci. Ther. 4, 335–340 (2012).
  CASGoogle Scholar
• 8 Bandopadhayay P, Jabbour AM, Riffkin C et al. The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts. BMC Cancer 13, 585 (2013).
  MedlineGoogle Scholar
• 9 Wang H, Peng R, Wang J, Qin Z, Xue L. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin. Epigenetics 10, 59 (2018).
  MedlineGoogle Scholar
• 10 Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat. Rev. Genet. 17(12), 719–732 (2016).
  Medline CASGoogle Scholar
• 11 Salehi M, Sharifi M. Exosomal miRNAs as novel cancer biomarkers: challenges and opportunities. J. Cell Physiol. 233(9), 6370–6380 (2018).
  Medline CASGoogle Scholar
• 12 Hoshino A, Costa-Silva B, Shen TL et al. Tumour exosome integrins determine organotropic metastasis. Nature 527(7578), 329–335 (2015). • Describing the specific targeting for certain sites of exosomes.
  Medline CASGoogle Scholar
• 13 Guduric-Fuchs J, O'Connor A, Camp B, O'Neill CL, Medina RJ, Simpson DA. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics 13, 357 (2012).
  Medline CASGoogle Scholar
• 14 Kim KY, Hwang YJ, Jung MK et al. A multifunctional protein EWS regulates the expression of drosha and microRNAs. Cell Death Differ. 21(1), 136–145 (2014).
  Medline CASGoogle Scholar
• 15 Masotti A, Alisi A. Integrated bioinformatics analysis of microRNA expression profiles for an in-depth understanding of pathogenic mechanisms in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 27(2), 187–188 (2012).
  Medline CASGoogle Scholar
• 16 Fan Y, Siklenka K, Arora SK, Ribeiro P, Kimmins S, Xia J. miRNet – dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res. 44(W1), W135–W141 (2016).
  Medline CASGoogle Scholar
• 17 Huang da W, Sherman BT, Zheng X et al. Extracting biological meaning from large gene lists with DAVID. Curr. Protoc. Bioinformatics Chapter 13: Unit 13.11 (2009).
  MedlineGoogle Scholar
• 18 Peng Y, Croce CM. The role of microRNAs in human cancer. Signal Transduct. Target Ther. 1, 15004 (2016).
  MedlineGoogle Scholar
• 19 Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007). •• The first evidence of the ability of exosomes to deliver nucleic acids to cells at a distance.
  Medline CASGoogle Scholar
• 20 Tang S, Chen Y, Feng S et al. MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma. Oncotarget 8(59), 99871–99888 (2017).
  MedlineGoogle Scholar
• 21 Sueta A, Yamamoto Y, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Iwase H. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence. Oncotarget 8(41), 69934–69944 (2017).
  MedlineGoogle Scholar
• 22 Zhang Y, Li T, Guo P et al. MiR-424-5p reversed epithelial–mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci. Rep. 4, 6248 (2014).
  Medline CASGoogle Scholar
• 23 Thor T, Künkele A, Pajtler KW et al. MiR-34a deficiency accelerates medulloblastoma formation in vivo. Int. J. Cancer 136(10), 2293–2303 (2015).
  Medline CASGoogle Scholar
• 24 Guessous F, Zhang Y, Kofman A et al. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 9(6), 1031–1036 (2010).
  Medline CASGoogle Scholar
• 25 Galardi A, Colletti M, Businaro P, Quintarelli C, Locatelli F, Di Giannatale A. MicroRNAs in neuroblastoma: biomarkers with therapeutic potential. Curr. Med. Chem. 25(5), 584–600 (2018). •• Very interesting review describing the role and the importance of several dysregulated miRNAs in a pediatric cancer such as neuroblastoma.
  Medline CASGoogle Scholar
• 26 Nan D, Haiying Wu, Tao T, Erxuan P. NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2. Onco Targets Ther. 10, 4905–4915 (2017).
  MedlineGoogle Scholar
• 27 Youguang P, Fangfang Z, Haiyan W, Shanbao C. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene. Sci. Rep. 7, 44218 (2017).
  MedlineGoogle Scholar
• 28 Youguang P, Fangfang Z, Yinpeng L et al. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene. BMC Cancer 17(1), 45 (2017).
  MedlineGoogle Scholar
• 29 Chen J, Wu FX, Luo HL et al. Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1. Am. J. Transl. Res. 8(11), 4932–4941 (2016).
  Medline CASGoogle Scholar
• 30 Lv KT, Liu Z, Feng J et al. MiR-22-3p Regulates cell proliferation and inhibits cell apoptosis through targeting the eIF4EBP3 gene in human cervical squamous carcinoma cells. Int. J. Med. Sci. 15(2), 142–152 (2018).
  Medline CASGoogle Scholar
• 31 Kuo WT, Yu SY, Li SC et al. MicroRNA-324 in human cancer: miR-324-5p and miR-324-3p have distinct biological functions in human cancer. Anticancer Res. 36(10), 5189–5196 (2016).
  Medline CASGoogle Scholar
• 32 Cao L, Xie B, Yang X et al. MiR-324-5p Suppresses hepatocellular carcinoma cell invasion by counteracting ECM degradation through post-transcriptionally downregulating ETS1 and SP1. PLoS ONE 10(7), e0133074 (2015).
  MedlineGoogle Scholar
• 33 Li XR, Chu HJ, Lv T, Wang L, Kong SF, Dai SZ. miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer. FEBS Lett. 588, 3298–3307 (2014).
  Medline CASGoogle Scholar
• 34 Xue X, Fei X, Hou W, Zhang Y, Liu L, Hu R. miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Lett. 412, 170–178 (2018).
  Medline CASGoogle Scholar
• 35 Liu W, Kang L, Han J et al. miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect. Onco. Targets Ther. 11, 1643–1653 (2018).
  MedlineGoogle Scholar
• 36 Leoncini PP, Bertaina A, Papaioannou D et al. MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment. Oncotarget 7(34), 55395–55408 (2016).
  MedlineGoogle Scholar
• 37 Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).
  MedlineGoogle Scholar
• 38 Bullock MD, Silva AM, Kanlikilicer-Unaldi P et al. Exosomal non-coding RNAs: ciagnostic, prognostic and therapeutic applications in cancer. Non-coding RNA 1(1), 53–68 (2015). •• Very intriguing review exploring the therapeutic and biomarker potential of exosomes with particular focus on the noncoding RNA, microRNA and long-noncoding RNA.
  MedlineGoogle Scholar
• 39 Yi-Lei Z, Ruo-Chen W, Ken C, Brian ZR, Li S. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol. Med. 14(1), 90–99 (2017).
  MedlineGoogle Scholar